Smith & Nephew plc (NYSE:SNN) is one of the best medical device stocks to invest in right now. Canaccord cut the price target on Smith & Nephew plc (NYSE:SNN) to $32 from $35 on April 24 and ...

Detailed price information for Smith & Nephew Snats ADR (SNN-N) from The Globe and Mail including charting and trades.

WTWH Healthcare is proud to introduce the inaugural Skilled Nursing News (SNN) Product of the Year (POY) Awards program. The inaugural SNN POY ...

While the proven Zacks Rank places an emphasis on earnings estimates and estimate revisions to find strong stocks, we also know that investors tend to develop their own individual strategies. With ...

Smith+Nephew SNN recently announced clinical evidence that demonstrates the superiority of its CARTIHEAL AGILI-C Cartilage ...

We rate Smith & Nephew a 'hold' due to technical resistance and underperformance versus the S&P 500. Dividend yield is modest and below inflation, with no growth in the past five years, limiting ...

Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop their ...

On April 27, Tom Lee, Fundstrat Capital Chief Investment Officer and Bitmine Immersion Technologies Chairman, appeared on ...

Oakmark Funds, advised by Harris Associates, released its “Oakmark International Fund” first quarter 2024 investor letter. A copy of the same can be downloaded here. For the quarter ended March 31, ...

Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop their ...